RxDoctor Payments Data

Benjamin Konell, DO

Family Medicine · Pace, FLNPI 1164512224

Payments from drug & device makers

$4,126in general payments, 2019–2025

Across 251 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$573
  • GSK$533
  • Astellas Pharma US Inc$504
  • AstraZeneca$441
  • Pfizer$282
  • Lilly USA, LLC$267
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$3,86394%
  • Education$2646%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,126 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$25,478
Medicare patients
174
Services billed
321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$47,069
MounjaroTirzepatide13$25,967
EliquisApixaban22$25,167
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$19,352
FarxigaDapagliflozin Propanediol14$15,035
XareltoRivaroxaban13$9,697
Breo ElliptaFluticasone/Vilanterol18$7,696
Gabapentin133$3,058
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen169$3,041
Albuterol Sulfate HfaAlbuterol Sulfate73$3,036
Omeprazole165$2,375
Duloxetine Hcl47$1,778
SynthroidLevothyroxine Sodium16$1,765
Atorvastatin Calcium244$1,753
Ventolin HfaAlbuterol Sulfate25$1,653

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$573$47,06925 claims
GSKTrelegy Ellipta, Breo Ellipta$533$27,04837 claims
Lilly USA, LLCMounjaro$267$25,96713 claims
PfizerEliquis$282$25,16722 claims
AstraZenecaFarxiga$441$15,03514 claims
Johnson & JohnsonXarelto$142$9,69713 claims
AbbVieSynthroid$227$1,76516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Pace

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →